Загрузка...
Sunitinib: the antiangiogenic effects and beyond
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma. Mechanistically, sunitinib inhibits multiple receptor tyrosine kinases, especially those involved in angiogen...
Сохранить в:
| Опубликовано в: : | Onco Targets Ther |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5021055/ https://ncbi.nlm.nih.gov/pubmed/27660467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S112242 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|